Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Jersey and you

Executive Summary

Former New Jersey Rep. Franks (R) named president of the pharmaceutical interest group HealthCare Institute of New Jersey, effective Aug. 1. During his four terms in the House, Franks co-sponsored legislation to extend the patent life for Schering-Plough's Claritin. Schering, Pfizer, Merck and Novartis contributed to Franks' campaigns, including his unsuccessful bid for Senate in 2000. Franks succeeds William Tremayne, who is retiring. The HealthCare Institute is chaired by Merck CEO Ray Gilmartin

You may also be interested in...

Rx Employees Being Mobilized For Political Advocacy By Former Rep. Franks

The HealthCare Institute of New Jersey is mobilizing the state's pharmaceutical employees to be involved in ongoing congressional debates on pricing issues

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts